20.07.2011 • NewsJohnson & JohnsonQ2 2011sales and profits

Johnson & Johnson Q2 Profit Down

Johnson & Johnson reported that its second-quarter net earnings were $2.776 billion or $1 per share, down from $3.449 billion or $1.23 per share in the same quarter last year. Adjusted net earnings rose to $3.548 billion or $1.28 per share, from $3.382 billion or $1.21 per share in the year ago quarter. Analysts polled by Thomson Reuters expected the company to report earnings of $1.23 per share for the quarter. Analysts' estimates typically exclude special items.

Sales for the quarter rose to $16.60 billion from $15.33 billion in the prior year quarter. Eleven analysts had consensus revenue estimate of $16.22 billion for the quarter.

The company maintained its earnings guidance for full-year 2011 of $4.90-$5 per share. Analysts expect the company to report earnings of $4.95 per share for fiscal 2011.

 

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read